메뉴 건너뛰기




Volumn 9, Issue 6, 1998, Pages 473-495

Serotonin and appetite regulation: Implications for the pharmacological treatment of obesity

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DEXFENFLURAMINE; FLUOXETINE; SEROTONIN; SIBUTRAMINE;

EID: 0031779626     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199809060-00005     Document Type: Review
Times cited : (78)

References (169)
  • 2
    • 0018573963 scopus 로고
    • Multiple serotonin receptors: Different binding of 3H-5-hydroxytryptamine, 3H-lysergic acid and diethylamide and 3H-spiroperidol
    • Peroutka SJ, Snyder SH. Multiple serotonin receptors: different binding of 3H-5-hydroxytryptamine, 3H-lysergic acid and diethylamide and 3H-spiroperidol. Mol Pharmacol 1979; 16: 687-99
    • (1979) Mol Pharmacol , vol.16 , pp. 687-699
    • Peroutka, S.J.1    Snyder, S.H.2
  • 3
    • 0022444356 scopus 로고
    • Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine
    • Bradley P, Engel G, Feniuk W, et al. (nomenclature committee) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 1986; 25: 563-76
    • (1986) Neuropharmacology , vol.25 , pp. 563-576
    • Bradley, P.1    Engel, G.2    Feniuk, W.3
  • 4
    • 0024463957 scopus 로고
    • Effector coupling mechanisms of the cloned 5-HT1A receptor
    • Fargin A, Raymond JR, Regan JW, et al. Effector coupling mechanisms of the cloned 5-HT1A receptor. J Biol Chem 1989; 264: 14848-52
    • (1989) J Biol Chem , vol.264 , pp. 14848-14852
    • Fargin, A.1    Raymond, J.R.2    Regan, J.W.3
  • 5
    • 0022483616 scopus 로고
    • Serotonin receptors in the human brain. I. Characterisation and autoradiographic localization of 5-HT1A recognition sites: Apparent absence of 5-HT1B recognition sites
    • Hover D, Pazos A, Probst A, et al. Serotonin receptors in the human brain. I. Characterisation and autoradiographic localization of 5-HT1A recognition sites: apparent absence of 5-HT1B recognition sites. Brain Res 1988; 376: 85-96.
    • (1988) Brain Res , vol.376 , pp. 85-96
    • Hover, D.1    Pazos, A.2    Probst, A.3
  • 6
    • 13344280365 scopus 로고    scopus 로고
    • Classification and nomenclature of 5-HT receptors: A comment on current issues
    • Hover D, Martin GR. Classification and nomenclature of 5-HT receptors: a comment on current issues. Behav Brain Res 1996; 73: 263-8
    • (1996) Behav Brain Res , vol.73 , pp. 263-268
    • Hover, D.1    Martin, G.R.2
  • 8
    • 0026647938 scopus 로고
    • Molecular cloning of a serotonin receptor from human brain (5-HT1E): A fifth 5-HT1-like sub-type
    • McAllister G, Charlesworth A, Snodin C, et al. Molecular cloning of a serotonin receptor from human brain (5-HT1E): a fifth 5-HT1-like sub-type. Proc Natl Acad Sci USA 1992; 89: 5517-21
    • (1992) Proc Natl Acad Sci USA , vol.89 , pp. 5517-5521
    • McAllister, G.1    Charlesworth, A.2    Snodin, C.3
  • 9
    • 0026733324 scopus 로고
    • Isolation of a mouse 5-HT1E-like receptor expressed predominantly in the hippocampus
    • Amlaiky N, Ramboz S, Boschert U, et al. Isolation of a mouse 5-HT1E-like receptor expressed predominantly in the hippocampus. J Biol Chem 1992; 92: 19761-4
    • (1992) J Biol Chem , vol.92 , pp. 19761-19764
    • Amlaiky, N.1    Ramboz, S.2    Boschert, U.3
  • 10
    • 0027534382 scopus 로고
    • Cloning of another human serotonin receptor (5-HT1F): A fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase
    • Adham N, Kao H-T, Schlechter L.E, et al. Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc Natl Acad Sci USA 1993; 89: 408-12
    • (1993) Proc Natl Acad Sci USA , vol.89 , pp. 408-412
    • Adham, N.1    Kao, H.-T.2    Schlechter, L.E.3
  • 11
    • 0011353846 scopus 로고
    • Agonists and antagonists at 5-HT receptor subtypes
    • Hoyer D. Agonists and antagonists at 5-HT receptor subtypes. Adv Biosci 1992; 85: 29-47
    • (1992) Adv Biosci , vol.85 , pp. 29-47
    • Hoyer, D.1
  • 12
    • 0023925856 scopus 로고
    • A 5-HT receptor in the nervous system positively coupled with adenylate cyclase is antagonised by ICS 205 930
    • Dumuis A, Boulelal R, Sebben M, et al. A 5-HT receptor in the nervous system positively coupled with adenylate cyclase is antagonised by ICS 205 930. Eur J Pharmacol 1988; 146: 187-8
    • (1988) Eur J Pharmacol , vol.146 , pp. 187-188
    • Dumuis, A.1    Boulelal, R.2    Sebben, M.3
  • 13
    • 0024466617 scopus 로고
    • The gastrointestinal prokinelic benzamide derivatives are agonists at a non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons
    • Dumuis A, Sebben M, Bockaert J. The gastrointestinal prokinelic benzamide derivatives are agonists at a non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons. Naunyn Schmiedebergs Arch Pharamacol 1989; 340: 403-10.
    • (1989) Naunyn Schmiedebergs Arch Pharamacol , vol.340 , pp. 403-410
    • Dumuis, A.1    Sebben, M.2    Bockaert, J.3
  • 14
    • 7144233713 scopus 로고
    • Evidence for a difference in mechanism of the action between fenfluramine and amphetamine induced anorexia
    • Jesperson S, Scheel-Kruger J. Evidence for a difference in mechanism of the action between fenfluramine and amphetamine induced anorexia. J Pharm Pharmacol 1973; 22: 637-8
    • (1973) J Pharm Pharmacol , vol.22 , pp. 637-638
    • Jesperson, S.1    Scheel-Kruger, J.2
  • 15
    • 0016840631 scopus 로고
    • Inhibition of drug-induced anorexia in rats by methysergide
    • Barrett AM, McSherry L. Inhibition of drug-induced anorexia in rats by methysergide. J Pharm Pharmacol 1975; 27: 889-95
    • (1975) J Pharm Pharmacol , vol.27 , pp. 889-895
    • Barrett, A.M.1    McSherry, L.2
  • 16
    • 0016816599 scopus 로고
    • Fenfluramine: A review of the pharmacological properties and therapeutic efficacy in obesity
    • Pinder BM, Brogden RN, Sawyer PR, et al. Fenfluramine: a review of the pharmacological properties and therapeutic efficacy in obesity. Drugs 1975; 10: 241-323
    • (1975) Drugs , vol.10 , pp. 241-323
    • Pinder, B.M.1    Brogden, R.N.2    Sawyer, P.R.3
  • 18
    • 0015366019 scopus 로고
    • Studies on food intake of genetically obese rats
    • Bray GA, York DA. Studies on food intake of genetically obese rats. Am J Physiol 1972; 223: 176-9
    • (1972) Am J Physiol , vol.223 , pp. 176-179
    • Bray, G.A.1    York, D.A.2
  • 19
    • 0442320794 scopus 로고
    • Evidence for the effect of tryptophan on the pattern of food consumption in rats
    • Latham CJ, Blundell JE. Evidence for the effect of tryptophan on the pattern of food consumption in rats. Life Sci 1979; 24: 1271-8
    • (1979) Life Sci , vol.24 , pp. 1271-1278
    • Latham, C.J.1    Blundell, J.E.2
  • 20
    • 0018569390 scopus 로고
    • Serotoninergic influences on food intake: Effect of 5-hydroxytryptophan on parameters of feeding behaviour in deprived and free-feeding rats
    • Blundell JE, Latham CJ. Serotoninergic influences on food intake: effect of 5-hydroxytryptophan on parameters of feeding behaviour in deprived and free-feeding rats. Pharmacol Biochem Behav 1979; 11: 431-7
    • (1979) Pharmacol Biochem Behav , vol.11 , pp. 431-437
    • Blundell, J.E.1    Latham, C.J.2
  • 21
    • 0018293713 scopus 로고
    • Hyperphagia following intraventricular p-chlorophenylalanine-, leucine-or tryptophan-methyl esters: Lack of correlation with whole brain serotonin level
    • MacKenzie RG, Hoebel BG, Ducret RP, et al. Hyperphagia following intraventricular p-chlorophenylalanine-, leucine-or tryptophan-methyl esters: lack of correlation with whole brain serotonin level. Pharmacol Biochem Behav 1979; 10: 951-5
    • (1979) Pharmacol Biochem Behav , vol.10 , pp. 951-955
    • MacKenzie, R.G.1    Hoebel, B.G.2    Ducret, R.P.3
  • 22
    • 0017563357 scopus 로고
    • Is there a role for serotonin (5-hydroxytryptamine) in feeding?
    • Blundell JE. Is there a role for serotonin (5-hydroxytryptamine) in feeding? Int J Obes 1977; 1: 15-42
    • (1977) Int J Obes , vol.1 , pp. 15-42
    • Blundell, J.E.1
  • 23
    • 0026669497 scopus 로고
    • Characterization of the human 5-HT1B receptor
    • Jin H, Oksenberg D, Askenzai A, et al. Characterization of the human 5-HT1B receptor. J Biol Chem 1992; 267 (9): 5735-8
    • (1992) J Biol Chem , vol.267 , Issue.9 , pp. 5735-5738
    • Jin, H.1    Oksenberg, D.2    Askenzai, A.3
  • 24
    • 0029400158 scopus 로고
    • Multiple serotonin receptors: Opportunities for new treatments for obesity
    • Dourish CT. Multiple serotonin receptors: opportunities for new treatments for obesity. Obes Res 1995; 3 Suppl.: 449-62s
    • (1995) Obes Res , vol.3 , Issue.SUPPL.
    • Dourish, C.T.1
  • 25
    • 0001538488 scopus 로고
    • The neuropharmacology of meal patterning
    • Cooper SJ, Hendrie CA, editors. Chichester: Wiley
    • Clifton PG. The neuropharmacology of meal patterning. In: Cooper SJ, Hendrie CA, editors. Ethology and psychopharmacology. Chichester: Wiley, 1994: 313-28
    • (1994) Ethology and Psychopharmacology , pp. 313-328
    • Clifton, P.G.1
  • 26
    • 0024496216 scopus 로고
    • Evidence that d-tenfluramine anorexia is mediated by 5-HT1 receptors
    • Neill JC, Cooper SJ. Evidence that d-tenfluramine anorexia is mediated by 5-HT1 receptors. Psychopharmacology 1989; 97: 213-8
    • (1989) Psychopharmacology , vol.97 , pp. 213-218
    • Neill, J.C.1    Cooper, S.J.2
  • 27
    • 0024591459 scopus 로고
    • Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity of d-fenfluramine in the rat
    • Samanin R, Mennini T, Bendotti C, et al. Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity of d-fenfluramine in the rat. Neuropharmacologv 1989; 28: 465-9
    • (1989) Neuropharmacologv , vol.28 , pp. 465-469
    • Samanin, R.1    Mennini, T.2    Bendotti, C.3
  • 28
    • 0025052357 scopus 로고
    • Studies on the role of 5-HT receptors in satiation and the effect of d-fenfluramine in the runway test
    • Neill JC, Bendotti C, Samanin R. Studies on the role of 5-HT receptors in satiation and the effect of d-fenfluramine in the runway test. Eur J Pharmacol 1990; 190: 105-12
    • (1990) Eur J Pharmacol , vol.190 , pp. 105-112
    • Neill, J.C.1    Bendotti, C.2    Samanin, R.3
  • 29
    • 0024155157 scopus 로고
    • Suppression of food intake in rats by fluoxetine: Comparison of enantiomers and effects of serotonin antagonists
    • Wong DT, Reid LR, Threlkeld PG. Suppression of food intake in rats by fluoxetine: comparison of enantiomers and effects of serotonin antagonists. Pharmacol Biochem Behav 1988; 31: 475-9
    • (1988) Pharmacol Biochem Behav , vol.31 , pp. 475-479
    • Wong, D.T.1    Reid, L.R.2    Threlkeld, P.G.3
  • 30
    • 0026587480 scopus 로고
    • Role of serotonin and catecholamines in brain in feeding suppressant effects of fluoxetine
    • Grignaschi G, Samanin R. Role of serotonin and catecholamines in brain in feeding suppressant effects of fluoxetine. Neuropharmacology 1992; 31: 445-9
    • (1992) Neuropharmacology , vol.31 , pp. 445-449
    • Grignaschi, G.1    Samanin, R.2
  • 31
    • 0026534847 scopus 로고
    • Partial reversal of fluoxetine anorexia by the 5-HT antagonist metergoline
    • Lee MD, Clifton PG. Partial reversal of fluoxetine anorexia by the 5-HT antagonist metergoline. Psychopharmacology 1992; 107: 359-64
    • (1992) Psychopharmacology , vol.107 , pp. 359-364
    • Lee, M.D.1    Clifton, P.G.2
  • 32
    • 0030218856 scopus 로고    scopus 로고
    • Metergoline antagonizes fluoxetine-induced suppression of food intake but not changes in the behavioural satiety sequence
    • Halford JCG, Blundell JE. Metergoline antagonizes fluoxetine-induced suppression of food intake but not changes in the behavioural satiety sequence. Pharmacol Biochem Behav 1996; 54: 745-51
    • (1996) Pharmacol Biochem Behav , vol.54 , pp. 745-751
    • Halford, J.C.G.1    Blundell, J.E.2
  • 33
    • 0031015701 scopus 로고    scopus 로고
    • Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability
    • Curzon G, Gibson EL, Oluyomi AO. Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. Trends Pharmacol Sci 1997; 18: 21-5
    • (1997) Trends Pharmacol Sci , vol.18 , pp. 21-25
    • Curzon, G.1    Gibson, E.L.2    Oluyomi, A.O.3
  • 34
    • 0029049224 scopus 로고
    • In vitro and in vivo effects of d-fenfluramine: No apparent relation between 5-hydroxytryptamine release and hypophagia
    • Raiteri M, Bonanno G, Vallebouona F. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia. J Pharmacol Exp Ther 1995; 273: 643-9
    • (1995) J Pharmacol Exp Ther , vol.273 , pp. 643-649
    • Raiteri, M.1    Bonanno, G.2    Vallebouona, F.3
  • 35
    • 0011722654 scopus 로고
    • Hypophagic effect of fluoxetine in rats is not mediated by inhibition of 5-HT re-uptake or an agonist action at 5-HT2C receptors
    • Lightowler S, Kennett GA, Wood MD, et al. Hypophagic effect of fluoxetine in rats is not mediated by inhibition of 5-HT re-uptake or an agonist action at 5-HT2C receptors. Br J Pharmacol 1994; 112: 359-64
    • (1994) Br J Pharmacol , vol.112 , pp. 359-364
    • Lightowler, S.1    Kennett, G.A.2    Wood, M.D.3
  • 36
    • 0020621792 scopus 로고
    • Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin
    • Koe BK, Weissman A, Welch WM, et al. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin. J Pharmacol Exp Ther 1983; 266: 686-700
    • (1983) J Pharmacol Exp Ther , vol.266 , pp. 686-700
    • Koe, B.K.1    Weissman, A.2    Welch, W.M.3
  • 37
    • 0023764826 scopus 로고
    • Reduction of feeding behaviour by the serotonin uptake inhibitor sertraline
    • Lucki I, Kreider MS, Simansky KJ. Reduction of feeding behaviour by the serotonin uptake inhibitor sertraline. Psychopharmacology 1988; 96: 289-95
    • (1988) Psychopharmacology , vol.96 , pp. 289-295
    • Lucki, I.1    Kreider, M.S.2    Simansky, K.J.3
  • 38
    • 0026510184 scopus 로고
    • A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: Evidence that dopamine is not a pharmacological target for sibutramine
    • Heal DJ, Frankland ATJ, Gosden J, et al. A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine. Psychopharmacology 1991; 107: 303-9
    • (1991) Psychopharmacology , vol.107 , pp. 303-309
    • Heal, D.J.1    Frankland, A.T.J.2    Gosden, J.3
  • 39
    • 0030759773 scopus 로고    scopus 로고
    • Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline re-uptake inhibitor, sibutramine, in the rat
    • Jackson HC, Bearham MC, Hutchins LJ, et al. Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline re-uptake inhibitor, sibutramine, in the rat. Br J Pharmacol 1997; 121: 1613-8
    • (1997) Br J Pharmacol , vol.121 , pp. 1613-1618
    • Jackson, H.C.1    Bearham, M.C.2    Hutchins, L.J.3
  • 40
    • 0026694080 scopus 로고
    • Biochemical and behavioural studies of the 5-HT1B receptor agonist, CP-94,253
    • Koe BK, Nielsen JA, Macor JE, et al. Biochemical and behavioural studies of the 5-HT1B receptor agonist, CP-94,253. Drug Dev Res 1992; 26: 241-50
    • (1992) Drug Dev Res , vol.26 , pp. 241-250
    • Koe, B.K.1    Nielsen, J.A.2    Macor, J.E.3
  • 41
    • 0030222490 scopus 로고    scopus 로고
    • The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence
    • Halford JCG, Blundell JE. The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence. Physiol Behav 1996; 60: 933-9
    • (1996) Physiol Behav , vol.60 , pp. 933-939
    • Halford, J.C.G.1    Blundell, J.E.2
  • 42
    • 0023161869 scopus 로고
    • 5-HT1B agonists induce anorexia at a post synaptic site
    • Kennett GA, Dourish CT, Curzon G. 5-HT1B agonists induce anorexia at a post synaptic site. Eur J Pharmacol 1987; 141: 429-35
    • (1987) Eur J Pharmacol , vol.141 , pp. 429-435
    • Kennett, G.A.1    Dourish, C.T.2    Curzon, G.3
  • 43
    • 0001595170 scopus 로고
    • Analysing the structure and sequence of feeding in animals and man
    • Christie WM, Weinman J, editors. Chichester: Wiley
    • Blundell JE, Alikhan H. Analysing the structure and sequence of feeding in animals and man. In: Christie WM, Weinman J, editors. Microcomputers, psychology and medicine. Chichester: Wiley, 1990: 203-25
    • (1990) Microcomputers, Psychology and Medicine , pp. 203-225
    • Blundell, J.E.1    Alikhan, H.2
  • 44
    • 0023894791 scopus 로고
    • Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors
    • Kennett GA, Curzon G. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol 1988; 94: 137-47
    • (1988) Br J Pharmacol , vol.94 , pp. 137-147
    • Kennett, G.A.1    Curzon, G.2
  • 45
    • 0023678368 scopus 로고
    • Evidence that the hxpophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors: Hypophagia induced by RU-24969 only requires 5-HT1B receptors
    • Kennett GA, Curzon G. Evidence that the hxpophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors: hypophagia induced by RU-24969 only requires 5-HT1B receptors. Psychopharmacology 1988; 96: 93-100
    • (1988) Psychopharmacology , vol.96 , pp. 93-100
    • Kennett, G.A.1    Curzon, G.2
  • 46
    • 0025613807 scopus 로고
    • Serotonin and appetite
    • Curzon G. Serotonin and appetite. Ann NY Acad Sci 1990; 600: 521-30
    • (1990) Ann NY Acad Sci , vol.600 , pp. 521-530
    • Curzon, G.1
  • 47
    • 0025949158 scopus 로고
    • Effects of tryptophan and 5-hydroxytryptamine receptor subtype agonists on feeding
    • Curzon G. Effects of tryptophan and 5-hydroxytryptamine receptor subtype agonists on feeding. Adv Exp Med Biol 1991; 294: 377-88
    • (1991) Adv Exp Med Biol , vol.294 , pp. 377-388
    • Curzon, G.1
  • 48
    • 0028300777 scopus 로고
    • In vivo properties of SB 200646A, a 5-HT2c/2b receptor antagonist
    • Kennett GA, Wood MD, Glen A, et al. In vivo properties of SB 200646A, a 5-HT2c/2b receptor antagonist. Br J Pharmacol 1994; 111: 797-802
    • (1994) Br J Pharmacol , vol.111 , pp. 797-802
    • Kennett, G.A.1    Wood, M.D.2    Glen, A.3
  • 49
    • 0018088673 scopus 로고
    • A 5-hydroxytryptamine like mode of action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212)
    • Clineschmidt BV, McGuffen JC, Pfleuger AB. A 5-hydroxytryptamine like mode of action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) Br J Pharmacol 1978; 62: 579-89
    • (1978) Br J Pharmacol , vol.62 , pp. 579-589
    • Clineschmidt, B.V.1    McGuffen, J.C.2    Pfleuger, A.B.3
  • 50
    • 0024434489 scopus 로고
    • MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1c receptor subtype
    • King BH, Brazell C, Dourish CT. MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1c receptor subtype. Neurosci Lett 1989; 105: 174-6
    • (1989) Neurosci Lett , vol.105 , pp. 174-176
    • King, B.H.1    Brazell, C.2    Dourish, C.T.3
  • 51
    • 0028307697 scopus 로고
    • 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors
    • Aulakh CS, Mazzola-Pomietto P, Wozniak KM, et al. 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors. J Pharmacol Exp Ther 1994; 270: 127-52
    • (1994) J Pharmacol Exp Ther , vol.270 , pp. 127-152
    • Aulakh, C.S.1    Mazzola-Pomietto, P.2    Wozniak, K.M.3
  • 52
    • 0029143139 scopus 로고
    • Lack of cross tolerance for hypophagia induced by DOI versus mCPP suggests separate mediation by 5-HT2A and 5-HT2c receptors respectively
    • Aulakh CS, Mazzola-Pomietto P, Hulihan-Giblin BA, et al. Lack of cross tolerance for hypophagia induced by DOI versus mCPP suggests separate mediation by 5-HT2A and 5-HT2c receptors respectively. Neuropsychopharmacology 1995; 13: 1-8
    • (1995) Neuropsychopharmacology , vol.13 , pp. 1-8
    • Aulakh, C.S.1    Mazzola-Pomietto, P.2    Hulihan-Giblin, B.A.3
  • 53
    • 0030636993 scopus 로고    scopus 로고
    • The 5-HT receptor agonist MK-212 reduces food intake but disrupts the behavioural satiety sequence
    • Halford JCG, Lawton CL, Blundell JE. The 5-HT receptor agonist MK-212 reduces food intake but disrupts the behavioural satiety sequence. Pharmacol Biochem Behav 1997; 56: 41-6
    • (1997) Pharmacol Biochem Behav , vol.56 , pp. 41-46
    • Halford, J.C.G.1    Lawton, C.L.2    Blundell, J.E.3
  • 54
    • 0025610262 scopus 로고
    • Behavioural mechanisms for the anorectic actions of the serotonin (5-HT) uptake inhibitor sertraline in rats: Comparison with directly acting agonists
    • Simansky KJ, Vaidya, AH. Behavioural mechanisms for the anorectic actions of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting agonists. Brain Res Bull 1990; 25: 953-60
    • (1990) Brain Res Bull , vol.25 , pp. 953-960
    • Simansky, K.J.1    Vaidya, A.H.2
  • 55
    • 0028909857 scopus 로고
    • Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors
    • Tecott LH, Sun LM, Akana SF, et al. Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors. Nature 1995; 374 (6522): 542-6
    • (1995) Nature , vol.374 , Issue.6522 , pp. 542-546
    • Tecott, L.H.1    Sun, L.M.2    Akana, S.F.3
  • 56
    • 0001851089 scopus 로고
    • Pharmacological manipulations of feeding behaviour: Possible influences of serotonin and dopamine on food intake
    • Garattini S, Samanin R, editors. New York: Raven Press
    • Blundell JE, Latham CJ. Pharmacological manipulations of feeding behaviour: possible influences of serotonin and dopamine on food intake. In: Garattini S, Samanin R, editors. Central mechanisms of anorectic drugs. New York: Raven Press, 1978: 83-109
    • (1978) Central Mechanisms of Anorectic Drugs , pp. 83-109
    • Blundell, J.E.1    Latham, C.J.2
  • 57
    • 0018940214 scopus 로고
    • Characteristic adjustments to the structure of feeding behaviour following pharmacological treatments: Effects of amphetamine and fenfluramine and the antagonism produced by pimozide and metergoline
    • Blundell JE, Latham CJ. Characteristic adjustments to the structure of feeding behaviour following pharmacological treatments: effects of amphetamine and fenfluramine and the antagonism produced by pimozide and metergoline. Pharmacol Biochem Behav 1980; 12: 717-22
    • (1980) Pharmacol Biochem Behav , vol.12 , pp. 717-722
    • Blundell, J.E.1    Latham, C.J.2
  • 58
    • 0022383490 scopus 로고
    • Behavioural structure and mechanisms of anorexia: Calibration of normal and abnormal inhibition of eating
    • Blundell JE, Rogers PJ, Hill AJ. Behavioural structure and mechanisms of anorexia: calibration of normal and abnormal inhibition of eating. Brain Res Bull 1985; 15: 319-26
    • (1985) Brain Res Bull , vol.15 , pp. 319-326
    • Blundell, J.E.1    Rogers, P.J.2    Hill, A.J.3
  • 59
    • 0016776704 scopus 로고
    • Cholecystokinin elicits the complete behavioural sequence of satiety in rats
    • Antin J, Gibbs J, Holt J, et al. Cholecystokinin elicits the complete behavioural sequence of satiety in rats. J Comp Physiol Psych 1975; 89: 784-60
    • (1975) J Comp Physiol Psych , vol.89 , pp. 784-860
    • Antin, J.1    Gibbs, J.2    Holt, J.3
  • 60
    • 0002692552 scopus 로고
    • Behavioural flux and feeding: Continuous monitoring of food intake and food selection, and the video-recording of appetitive and satiety sequences for the analysis of drug action
    • Samanin R, Garittini S, editors. New York: Raven Press
    • Blundell JE, McArthur RA. Behavioural flux and feeding: continuous monitoring of food intake and food selection, and the video-recording of appetitive and satiety sequences for the analysis of drug action. In: Samanin R, Garittini S, editors. Anorectic agents: mechanisms of action and tolerance. New York: Raven Press, 1981: 19-43
    • (1981) Anorectic Agents: Mechanisms of Action and Tolerance , pp. 19-43
    • Blundell, J.E.1    McArthur, R.A.2
  • 62
    • 0002015523 scopus 로고
    • 5-hydroxytrytaminergic drugs compared on the behavioural sequence associated with satiety
    • Halford JCG, Blundell JE. 5-hydroxytrytaminergic drugs compared on the behavioural sequence associated with satiety [abstract]. Br J Pharmacol 1993; 100: 95p
    • (1993) Br J Pharmacol , vol.100
    • Halford, J.C.G.1    Blundell, J.E.2
  • 63
    • 0023876415 scopus 로고
    • Fenfluramine disrupts the behavioural satiety sequence in rats
    • Montgomery AMJ, Willner P. Fenfluramine disrupts the behavioural satiety sequence in rats. Psychopharmacology 1988; 94: 397-401
    • (1988) Psychopharmacology , vol.94 , pp. 397-401
    • Montgomery, A.M.J.1    Willner, P.2
  • 64
    • 0025105694 scopus 로고
    • Behavioural analysis of the anorectic effects of fluoxetine and fenfluramine
    • Willner P, McGuirk J, Phillips G, et al. Behavioural analysis of the anorectic effects of fluoxetine and fenfluramine. Psychopharmacology 1990; 102: 273-7
    • (1990) Psychopharmacology , vol.102 , pp. 273-277
    • Willner, P.1    McGuirk, J.2    Phillips, G.3
  • 65
    • 0026611434 scopus 로고
    • Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence
    • McGuirk J, Muscat R, Willner P. Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence. Psychopharmacology 1992; 107: 401-7
    • (1992) Psychopharmacology , vol.107 , pp. 401-407
    • McGuirk, J.1    Muscat, R.2    Willner, P.3
  • 66
    • 0026555904 scopus 로고
    • Effects of the 5-HT uptake inhibitors femoxitine and paroxetine, and the 5-HT1A agonist citalopram, on the behavioural satiety sequence
    • McGuirk J, Muscat R, Willner P. Effects of the 5-HT uptake inhibitors femoxitine and paroxetine, and the 5-HT1A agonist citalopram, on the behavioural satiety sequence. Pharmacol Biochem Behav 1992; 41: 801-5
    • (1992) Pharmacol Biochem Behav , vol.41 , pp. 801-805
    • McGuirk, J.1    Muscat, R.2    Willner, P.3
  • 67
    • 0001612783 scopus 로고
    • Effects in the rat of sibutramine on food intake and the behavioural satiety sequence
    • Halford JCG, Heal DJ, Blundell JE. Effects in the rat of sibutramine on food intake and the behavioural satiety sequence [abstract]. Br J Pharmacol 1995; 114: 378p
    • (1995) Br J Pharmacol , vol.114
    • Halford, J.C.G.1    Heal, D.J.2    Blundell, J.E.3
  • 68
    • 0028298214 scopus 로고
    • An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats
    • Kitchener SJ, Dourish CT. An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats. Psychopharmacology 1994; 113: 369-77
    • (1994) Psychopharmacology , vol.113 , pp. 369-377
    • Kitchener, S.J.1    Dourish, C.T.2
  • 69
    • 0026516805 scopus 로고
    • CCK antagonists and CCK-monoamine interactions in the control of satiety
    • Cooper SJ, Dourish CT, Clifton PG. CCK antagonists and CCK-monoamine interactions in the control of satiety. Am J Clin Nutr 1992; 55 Suppl.: 291s-295s
    • (1992) Am J Clin Nutr , vol.55 , Issue.SUPPL.
    • Cooper, S.J.1    Dourish, C.T.2    Clifton, P.G.3
  • 70
    • 0027299411 scopus 로고
    • Reciprocal interaction of 5-hydroxytryptamine and cholecystokinin in the control of feeding
    • Grignaschi G, Mantelli B, Fracasso C, et al. Reciprocal interaction of 5-hydroxytryptamine and cholecystokinin in the control of feeding. Br J Pharmacol 1993; 109 (2): 491-4
    • (1993) Br J Pharmacol , vol.109 , Issue.2 , pp. 491-494
    • Grignaschi, G.1    Mantelli, B.2    Fracasso, C.3
  • 71
    • 0028988108 scopus 로고
    • Evidence for the involvement of the 5-HT1A receptor in CCK-induced satiety in rats
    • Voigt JP, Fink H, Marsden CA. Evidence for the involvement of the 5-HT1A receptor in CCK-induced satiety in rats. Naunyn Schmiedebergs Arch Pharmacol 1995; 351: 217-20
    • (1995) Naunyn Schmiedebergs Arch Pharmacol , vol.351 , pp. 217-220
    • Voigt, J.P.1    Fink, H.2    Marsden, C.A.3
  • 72
    • 0027398306 scopus 로고
    • Cholecystokinin-induced satiety depends on the activation of 5-HT1C receptors
    • Poeschla B, Gibbs J, Simansky KJ, et al. Cholecystokinin-induced satiety depends on the activation of 5-HT1C receptors. Am J Physiol 1993; 264: R62-4
    • (1993) Am J Physiol , vol.264
    • Poeschla, B.1    Gibbs, J.2    Simansky, K.J.3
  • 73
    • 0026611486 scopus 로고
    • The 5-HT1A agonist 8-OH-DPAT attenuated the satiating action of cholecystokinin
    • Poeschla B, Gibbs J, Simansky KJ, et al. The 5-HT1A agonist 8-OH-DPAT attenuated the satiating action of cholecystokinin. Pharmacol Biochem Behav 1992; 42: 541-3
    • (1992) Pharmacol Biochem Behav , vol.42 , pp. 541-543
    • Poeschla, B.1    Gibbs, J.2    Simansky, K.J.3
  • 74
    • 0025280635 scopus 로고
    • 3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3.2-b]pyrid-5-one: A potent and selective 5-HT1B agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyid-4-yl)indole
    • Macor JE, Burkhart CA, Heym JH, et al. 3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3.2-b]pyrid-5-one: a potent and selective 5-HT1B agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyid-4-yl)indole. J Med Chem 1990; 33: 2087-93
    • (1990) J Med Chem , vol.33 , pp. 2087-2093
    • Macor, J.E.1    Burkhart, C.A.2    Heym, J.H.3
  • 75
    • 0028985410 scopus 로고
    • The 5-HT1B receptor mediates the effect of d-fenfluramine on eating caused by intrahypothalamic injection of neuropeptide Y
    • Grignaschi G, Sironi F, Samanin R. The 5-HT1B receptor mediates the effect of d-fenfluramine on eating caused by intrahypothalamic injection of neuropeptide Y. Eur J Pharmacol 1995; 274: 221-4
    • (1995) Eur J Pharmacol , vol.274 , pp. 221-224
    • Grignaschi, G.1    Sironi, F.2    Samanin, R.3
  • 76
    • 0028847195 scopus 로고
    • The serotonin (5-HT) antagonist methysergide increases neuropeptide Y (NPY) synthesis and secretion in the hypothalamus of the rat
    • Dryden S, Wang Q, Krankish HM, et al. The serotonin (5-HT) antagonist methysergide increases neuropeptide Y (NPY) synthesis and secretion in the hypothalamus of the rat. Brain Res 1995; 699: 12-8
    • (1995) Brain Res , vol.699 , pp. 12-18
    • Dryden, S.1    Wang, Q.2    Krankish, H.M.3
  • 77
    • 0030591469 scopus 로고    scopus 로고
    • Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine
    • Dryden S, Frankish HM, Wang Q, et al. Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine. Brain Res 1996; 724: 232-7
    • (1996) Brain Res , vol.724 , pp. 232-237
    • Dryden, S.1    Frankish, H.M.2    Wang, Q.3
  • 78
    • 0029985448 scopus 로고    scopus 로고
    • The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats
    • Dryden S, Prankish HM, Wang Q, et al. The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats. Neuroscience 1996; 72: 557-66
    • (1996) Neuroscience , vol.72 , pp. 557-566
    • Dryden, S.1    Prankish, H.M.2    Wang, Q.3
  • 79
    • 0023719763 scopus 로고
    • Infusion of the 5-hydroxytryptamine agonists RU-24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia
    • Hutson PH, Donohoe TP, Curzon G. Infusion of the 5-hydroxytryptamine agonists RU-24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology 1988; 97: 550-2
    • (1988) Psychopharmacology , vol.97 , pp. 550-552
    • Hutson, P.H.1    Donohoe, T.P.2    Curzon, G.3
  • 80
    • 0027421365 scopus 로고
    • Injecting 5-HT into the PVN does not prevent feeding induced by 8-OH-DPAT into the raphe
    • Fletcher PJ, Coscina DV. Injecting 5-HT into the PVN does not prevent feeding induced by 8-OH-DPAT into the raphe. Pharmacol Biochem Behav 1993; 46: 487-91
    • (1993) Pharmacol Biochem Behav , vol.46 , pp. 487-491
    • Fletcher, P.J.1    Coscina, D.V.2
  • 81
    • 0028289642 scopus 로고
    • Intra-ventricular but not intra-paraventricular nucleus metergoline elicits feeding in satiated rats
    • Coscina DV, Feifel D, Nobrega JN, et al. Intra-ventricular but not intra-paraventricular nucleus metergoline elicits feeding in satiated rats. Am J Physiol 1994); 266: r1562-7
    • (1994) Am J Physiol , vol.266
    • Coscina, D.V.1    Feifel, D.2    Nobrega, J.N.3
  • 82
    • 0029968883 scopus 로고    scopus 로고
    • Metergoline potentiates natural feeding and antagonizes the anorectic action of medial hypothalamic 5-HT
    • Currie PJ, Coscina DV. Metergoline potentiates natural feeding and antagonizes the anorectic action of medial hypothalamic 5-HT. Pharmacol Biochem Behav 1996; 53: 1023-8
    • (1996) Pharmacol Biochem Behav , vol.53 , pp. 1023-1028
    • Currie, P.J.1    Coscina, D.V.2
  • 83
    • 0001874278 scopus 로고    scopus 로고
    • The role of hypothalamic peptides in the control of energy balance and body weight
    • Dryden S, Williams G. The role of hypothalamic peptides in the control of energy balance and body weight. Curr Opin Endocrinol Diabetes 1996; 3: 51-8
    • (1996) Curr Opin Endocrinol Diabetes , vol.3 , pp. 51-58
    • Dryden, S.1    Williams, G.2
  • 84
    • 0028048885 scopus 로고
    • The importance of 5-hydroxytryptamine receptors in the gut
    • Read NW, Gwee KA. The importance of 5-hydroxytryptamine receptors in the gut. Pharmacol Ther 1994; 62: 159-73
    • (1994) Pharmacol Ther , vol.62 , pp. 159-173
    • Read, N.W.1    Gwee, K.A.2
  • 85
    • 0028900628 scopus 로고
    • Comparisons between the effects of 5-HT and dl-fenfluramine on food intake and gastric emptying in the rat
    • Francis J, Critchley D, Dourish CT, et al. Comparisons between the effects of 5-HT and dl-fenfluramine on food intake and gastric emptying in the rat. Pharmacol Biochem Behav 1995; 50: 581-5
    • (1995) Pharmacol Biochem Behav , vol.50 , pp. 581-585
    • Francis, J.1    Critchley, D.2    Dourish, C.T.3
  • 86
    • 0026015104 scopus 로고
    • Peripherally administered 5-hydroxytryptamine elicits the full behavioural satiety sequence
    • Edwards S, Stevens R. Peripherally administered 5-hydroxytryptamine elicits the full behavioural satiety sequence. Physiol Behav 1991; 50: 1075-7
    • (1991) Physiol Behav , vol.50 , pp. 1075-1077
    • Edwards, S.1    Stevens, R.2
  • 87
    • 7144227374 scopus 로고    scopus 로고
    • Serotoninergic control of the organization of feeding and satiety
    • Simansky KJ. Serotoninergic control of the organization of feeding and satiety. Behav Brain Res 1996; 73: 37-42
    • (1996) Behav Brain Res , vol.73 , pp. 37-42
    • Simansky, K.J.1
  • 88
    • 0029914533 scopus 로고    scopus 로고
    • Energy density and its role in the control of food intake: Evidence from metabolic and community studies
    • Poppitt SD, Prentice AM. Energy density and its role in the control of food intake: evidence from metabolic and community studies. Appetite 1996; 26: 153-74
    • (1996) Appetite , vol.26 , pp. 153-174
    • Poppitt, S.D.1    Prentice, A.M.2
  • 89
    • 0029813438 scopus 로고    scopus 로고
    • High and low fat consumers, their macronutrient intake and body mass index: Further analysis of the National Diet and Nutrition Survey of British adults
    • MacDiaramid JI, Cade JE, Blundell JE. High and low fat consumers, their macronutrient intake and body mass index: further analysis of the National Diet and Nutrition Survey of British adults. Eur J Clin Nutr 1997; 50 (8): 505-12
    • (1997) Eur J Clin Nutr , vol.50 , Issue.8 , pp. 505-512
    • MacDiaramid, J.I.1    Cade, J.E.2    Blundell, J.E.3
  • 90
    • 0029031491 scopus 로고
    • Fat and carbohydrate overfeeding in humans: Different effects on energy storage
    • Horton TJ, Drougas H, Brachey A, et al. Fat and carbohydrate overfeeding in humans: different effects on energy storage. Am J Clin Nutr 1995; 62: 19-29
    • (1995) Am J Clin Nutr , vol.62 , pp. 19-29
    • Horton, T.J.1    Drougas, H.2    Brachey, A.3
  • 91
    • 7144238319 scopus 로고
    • Control of brain 5-HT content by dietary carbohydrates
    • Barchas J, Usdin E, editors. New York: Academic Press
    • Fernstrom JD, Wurtman RJ. Control of brain 5-HT content by dietary carbohydrates. In: Barchas J, Usdin E, editors. Serotonin and behaviour. New York: Academic Press, 1973: 121-8
    • (1973) Serotonin and Behaviour , pp. 121-128
    • Fernstrom, J.D.1    Wurtman, R.J.2
  • 92
    • 0016136716 scopus 로고
    • Effects of diet on brain neurotransmitters
    • Wurtman RJ, Fernstrom JD. Effects of diet on brain neurotransmitters. Nutr Rev 1974; 32: 193-200
    • (1974) Nutr Rev , vol.32 , pp. 193-200
    • Wurtman, R.J.1    Fernstrom, J.D.2
  • 93
    • 0024819055 scopus 로고
    • The effect of protein or carbohydrate breakfasts on subsequent plasma amino acid levels, satiety and nutrient selection in normal males
    • Teff KL, Young SN, Blundell JE. The effect of protein or carbohydrate breakfasts on subsequent plasma amino acid levels, satiety and nutrient selection in normal males. Pharmacol Biochem Behav 1989; 34: 410-7
    • (1989) Pharmacol Biochem Behav , vol.34 , pp. 410-417
    • Teff, K.L.1    Young, S.N.2    Blundell, J.E.3
  • 94
    • 0023355378 scopus 로고
    • Nutrition, serotonin and appetite: Case studying the evolution of a scientific idea
    • Blundell JE, Hill AJ. Nutrition, serotonin and appetite: case studying the evolution of a scientific idea. Appetite 1987; 8: 183-94
    • (1987) Appetite , vol.8 , pp. 183-194
    • Blundell, J.E.1    Hill, A.J.2
  • 95
    • 1642463095 scopus 로고
    • Effect of diet composition on affective state in anorexia nervosa and hulimia
    • Pirke KM, Schweiger U, Laessle RG. Effect of diet composition on affective state in anorexia nervosa and hulimia. Clin Neuropharmacol 1986; 9: 513-5
    • (1986) Clin Neuropharmacol , vol.9 , pp. 513-515
    • Pirke, K.M.1    Schweiger, U.2    Laessle, R.G.3
  • 96
    • 0022366113 scopus 로고
    • Evidence for diminished brain 5-HT biosynthesis in obese diabetic and non-diabetic humans
    • Ashley DVM, Fleury MO, Golay A, et al. Evidence for diminished brain 5-HT biosynthesis in obese diabetic and non-diabetic humans. Am J Clin Nutr 1985; 42: 1240-5
    • (1985) Am J Clin Nutr , vol.42 , pp. 1240-1245
    • Ashley, D.V.M.1    Fleury, M.O.2    Golay, A.3
  • 97
    • 0028892925 scopus 로고
    • Toward a unified theory of serotonin dysregulation in eating and related disorders
    • Brewerton TD. Toward a unified theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinology 1995; 20: 561-90
    • (1995) Psychoneuroendocrinology , vol.20 , pp. 561-590
    • Brewerton, T.D.1
  • 98
    • 0023641220 scopus 로고
    • Dieting changes 5-HT function in women, not in men: Implications for the aetiology of anorexia nervosa?
    • Goodwin GM, Fairburn CG, Cowen PJ. Dieting changes 5-HT function in women, not in men: implications for the aetiology of anorexia nervosa? Psychol Med 1987; 17: 839-42
    • (1987) Psychol Med , vol.17 , pp. 839-842
    • Goodwin, G.M.1    Fairburn, C.G.2    Cowen, P.J.3
  • 99
    • 0025311843 scopus 로고
    • Plasma concentrations of tryptophan and dieting
    • Goodwin GM, Cowen PJ, Fairburn CJ, et al. Plasma concentrations of tryptophan and dieting. BMJ 1990; 300: 1499-500
    • (1990) BMJ , vol.300 , pp. 1499-1500
    • Goodwin, G.M.1    Cowen, P.J.2    Fairburn, C.J.3
  • 100
    • 0000404006 scopus 로고
    • Problems and processes underlying the control of food selection and nutrient intake
    • Wurtman RJ, Wurtman JJ, editors. New York: Raven Press
    • Blundell JE. Problems and processes underlying the control of food selection and nutrient intake. In: Wurtman RJ, Wurtman JJ, editors. Nutrition and the brain. Vol 6. New York: Raven Press, 1983: 163-222
    • (1983) Nutrition and the Brain , vol.6 , pp. 163-222
    • Blundell, J.E.1
  • 101
    • 0025285884 scopus 로고
    • Food intake and selection pattern of rats treated with dexfenfluramine, fluoxetine and RU-24969
    • Luo S, Li ETS. Food intake and selection pattern of rats treated with dexfenfluramine, fluoxetine and RU-24969. Brain Res Bull 1990; 24: 729-33
    • (1990) Brain Res Bull , vol.24 , pp. 729-733
    • Luo, S.1    Li, E.T.S.2
  • 102
    • 0026495413 scopus 로고
    • The effects of d-fenfluramine on intake of carhohydrate supplements is influenced by the hydration of the test diets
    • Lawton CL, Blundell JE. The effects of d-fenfluramine on intake of carhohydrate supplements is influenced by the hydration of the test diets. Physiol Behav 1992; 3: 517-23
    • (1992) Physiol Behav , vol.3 , pp. 517-523
    • Lawton, C.L.1    Blundell, J.E.2
  • 103
    • 0027281675 scopus 로고
    • 5-HT manipulation and dietary choice: Variable carbohydrate (polycose) suppression demonstrated only under specific experimental conditions
    • Lawton CL, Blundell JE. 5-HT manipulation and dietary choice: variable carbohydrate (polycose) suppression demonstrated only under specific experimental conditions. Psychopharmacology 1993; 112: 375-82
    • (1993) Psychopharmacology , vol.112 , pp. 375-382
    • Lawton, C.L.1    Blundell, J.E.2
  • 104
    • 7144240994 scopus 로고
    • Serotonin administration selectively reduces fat intake in rats
    • Kanarek RB, Dushkin H. Serotonin administration selectively reduces fat intake in rats. Pharmacol Biochem Behav 1988; 13: 133-22
    • (1988) Pharmacol Biochem Behav , vol.13 , pp. 133-222
    • Kanarek, R.B.1    Dushkin, H.2
  • 105
    • 0022500886 scopus 로고
    • Brain serotonin and eating behaviour
    • Leibowitz SF, Shor-Posner G. Brain serotonin and eating behaviour. Appetite 1986; 7: 1-14
    • (1986) Appetite , vol.7 , pp. 1-14
    • Leibowitz, S.F.1    Shor-Posner, G.2
  • 106
    • 0021736711 scopus 로고
    • Meal patterns and food selection during the development of obesity in rats fed a cafeteria diet
    • Rogers PJ, Blundell JE. Meal patterns and food selection during the development of obesity in rats fed a cafeteria diet. Neurosci Biobehav Rev 1984; 8: 441-53
    • (1984) Neurosci Biobehav Rev , vol.8 , pp. 441-453
    • Rogers, P.J.1    Blundell, J.E.2
  • 107
    • 0021705710 scopus 로고
    • Animal models of obesity: Classification and characterisation
    • Sclafani A. Animal models of obesity: classification and characterisation. Int J Obes 1984; 8: 491-508
    • (1984) Int J Obes , vol.8 , pp. 491-508
    • Sclafani, A.1
  • 108
    • 7144244721 scopus 로고
    • Energy intake of rats fed a cafeteria diet
    • Prats E, Monfar M, Castella J, et al. Energy intake of rats fed a cafeteria diet. Physiol Behav 1989; 45: 2263-72
    • (1989) Physiol Behav , vol.45 , pp. 2263-2272
    • Prats, E.1    Monfar, M.2    Castella, J.3
  • 109
    • 0039625220 scopus 로고
    • Effects of dexfenfluramine in feeding and body weight: Relationship with food consumption and palatability
    • Vague J, Guy-Grand B, Bjontroup P, editors. Nordlolland: Elsevier
    • Blundell JE, Hill AJ. Effects of dexfenfluramine in feeding and body weight: relationship with food consumption and palatability. In: Vague J, Guy-Grand B, Bjontroup P, editors. Metabolic complication of human obesities. Nordlolland: Elsevier, 1985: 199-206
    • (1985) Metabolic Complication of Human Obesities , pp. 199-206
    • Blundell, J.E.1    Hill, A.J.2
  • 110
  • 111
    • 0024164562 scopus 로고
    • Do serotoninergic drugs decrease energy intake by reducing fat or carbohydrate intake? Effect of d-fenfluramine with supplemented weight increase diets
    • Blundell JE, Hill AJ. Do serotoninergic drugs decrease energy intake by reducing fat or carbohydrate intake? Effect of d-fenfluramine with supplemented weight increase diets. Pharmacol Biochem Behav 1989; 31: 773-8
    • (1989) Pharmacol Biochem Behav , vol.31 , pp. 773-778
    • Blundell, J.E.1    Hill, A.J.2
  • 112
    • 0029400216 scopus 로고
    • Serotonin, eating behaviour and fat intake
    • Blundell JE, Lawton CL, Halford JCG. Serotonin, eating behaviour and fat intake. Obes Res 1995; 3 Suppl. 4: 471-6
    • (1995) Obes Res , vol.3 , Issue.4 SUPPL. , pp. 471-476
    • Blundell, J.E.1    Lawton, C.L.2    Halford, J.C.G.3
  • 113
    • 0343912960 scopus 로고
    • Model system for investigating the actions of anorectic drugs: Effects of d-fenfluramine on food intake, nutrient selection, food preferences, meal patterns, hunger and satiety in healthy human subjects
    • Oxford: Pergamon Press
    • Hill AJ, Blundell JE. Model system for investigating the actions of anorectic drugs: effects of d-fenfluramine on food intake, nutrient selection, food preferences, meal patterns, hunger and satiety in healthy human subjects. Advances in the biosciences. Oxford: Pergamon Press, 1986: 377-89
    • (1986) Advances in the Biosciences , pp. 377-389
    • Hill, A.J.1    Blundell, J.E.2
  • 114
    • 0024213018 scopus 로고
    • Differential effect of d-fenfluramine and metergoline on food intake in human subjects
    • Goodall EM, Silverstone T. Differential effect of d-fenfluramine and metergoline on food intake in human subjects. Appetite 1988; 11: 215-8
    • (1988) Appetite , vol.11 , pp. 215-218
    • Goodall, E.M.1    Silverstone, T.2
  • 115
    • 0023769815 scopus 로고
    • On the mechanism of action of dexfenfluramine: Effect on alliesthesia and appetite motivation in lean and obese subjects
    • Blundell JE, Hill AJ. On the mechanism of action of dexfenfluramine: effect on alliesthesia and appetite motivation in lean and obese subjects. Clin Neuropharmacol 1988; 11 Suppl. 1: 121S-34S
    • (1988) Clin Neuropharmacol , vol.11 , Issue.1 SUPPL.
    • Blundell, J.E.1    Hill, A.J.2
  • 116
    • 0025355281 scopus 로고
    • Sensitivity of the appetite control system in obese subjects to nutritional and serotoninergic challenges
    • Hill AJ, Blundell JE. Sensitivity of the appetite control system in obese subjects to nutritional and serotoninergic challenges. Int J Obes 1990; 14: 219-33
    • (1990) Int J Obes , vol.14 , pp. 219-233
    • Hill, A.J.1    Blundell, J.E.2
  • 117
    • 0029032626 scopus 로고
    • Techniques for the experimental measurement of human eating behaviour: A practical guide
    • Hill AJ, Rogers PJ, Blundell JE. Techniques for the experimental measurement of human eating behaviour: a practical guide. Int J Obes 1995; 19: 361-75
    • (1995) Int J Obes , vol.19 , pp. 361-375
    • Hill, A.J.1    Rogers, P.J.2    Blundell, J.E.3
  • 118
    • 0029330841 scopus 로고
    • Serotoninergic manipulation, meal-induced satiety and eating pattern: Effects of fluoxeline in obese female subjects
    • Lawton CL, Wales JK, Hill AJ, et al. Serotoninergic manipulation, meal-induced satiety and eating pattern: effects of fluoxeline in obese female subjects. Obes Res 1995; 3: 345-56
    • (1995) Obes Res , vol.3 , pp. 345-356
    • Lawton, C.L.1    Wales, J.K.2    Hill, A.J.3
  • 119
    • 0031602176 scopus 로고    scopus 로고
    • Sibutramine reduces food intake in non-dieting women with obesity
    • Rolls BJ, Shide DJ, Thorwart ML, et al. Sibutramine reduces food intake in non-dieting women with obesity. Obes Res 1998; 6: 1-11
    • (1998) Obes Res , vol.6 , pp. 1-11
    • Rolls, B.J.1    Shide, D.J.2    Thorwart, M.L.3
  • 120
    • 7144219914 scopus 로고    scopus 로고
    • Moderate dieting causes 5-HT2C supersensitization
    • Cowen PJ, Clifford EM, Walsh AE, et al. Moderate dieting causes 5-HT2C supersensitization. Psychol Med 1996; 26: 1156-9
    • (1996) Psychol Med , vol.26 , pp. 1156-1159
    • Cowen, P.J.1    Clifford, E.M.2    Walsh, A.E.3
  • 121
    • 0026446889 scopus 로고
    • Eating behaviour and adherence to dietary prescription in obese adult subjects treated with 5-hydroxytryptophan
    • Cangiano C, Ceci F, Casinco A, et al. Eating behaviour and adherence to dietary prescription in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin Nutr 1992; 56: 863-7
    • (1992) Am J Clin Nutr , vol.56 , pp. 863-867
    • Cangiano, C.1    Ceci, F.2    Casinco, A.3
  • 122
    • 0029402012 scopus 로고
    • Sertraline and relapse prevention following treatment by a very low calorie diet: A controlled clinical trial
    • Wadden TA, Bartlett SJ, Foster GD, et al. Sertraline and relapse prevention following treatment by a very low calorie diet: a controlled clinical trial. Obes Res 1995; 3 (6): 549-7
    • (1995) Obes Res , vol.3 , Issue.6 , pp. 549-557
    • Wadden, T.A.1    Bartlett, S.J.2    Foster, G.D.3
  • 123
    • 0021607738 scopus 로고
    • The clinical pharmacology of appetite suppressant drugs
    • Silverstone T, Goodall E. The clinical pharmacology of appetite suppressant drugs. Int J Obes 1984; 8 (1): 23-33
    • (1984) Int J Obes , vol.8 , Issue.1 , pp. 23-33
    • Silverstone, T.1    Goodall, E.2
  • 124
    • 0018627511 scopus 로고
    • Effect of anorexic drugs on food intake and the micro-structure of eating in human subjects
    • Rogers PJ, Blundell JE. Effect of anorexic drugs on food intake and the micro-structure of eating in human subjects. Psychopharmacology 1979; 66: 159-65
    • (1979) Psychopharmacology , vol.66 , pp. 159-165
    • Rogers, P.J.1    Blundell, J.E.2
  • 125
    • 85005297514 scopus 로고
    • Carbohydrate craving in obese people: Suppression by treatments affecting serotoninergic transmission
    • Wurtman JJ, Wurtmann RJ, Growdon JH, et al. Carbohydrate craving in obese people: suppression by treatments affecting serotoninergic transmission. Int J Eat Disord 1982; 1: 2-15
    • (1982) Int J Eat Disord , vol.1 , pp. 2-15
    • Wurtman, J.J.1    Wurtmann, R.J.2    Growdon, J.H.3
  • 126
    • 0021923986 scopus 로고
    • d-Fenfluramine selectively suppresses carbohydrate snacking in obese subjects
    • Wurtman JJ, Wurtman RJ, Mark S, et al. d-Fenfluramine selectively suppresses carbohydrate snacking in obese subjects. Int J Eat Disord 1985; 4: 89-99
    • (1985) Int J Eat Disord , vol.4 , pp. 89-99
    • Wurtman, J.J.1    Wurtman, R.J.2    Mark, S.3
  • 127
    • 0027360166 scopus 로고
    • Ritanserin attenuates anorectic endocrine and thermic responses to d-fenfluramine in human volunteers
    • Goodall EM, Cowen PJ, Franklin M, et al. Ritanserin attenuates anorectic endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacology 1993; 112: 461-6
    • (1993) Psychopharmacology , vol.112 , pp. 461-466
    • Goodall, E.M.1    Cowen, P.J.2    Franklin, M.3
  • 128
    • 0025329192 scopus 로고
    • The effect of 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects
    • McGuirk J, Silverstone T. The effect of 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects. Int J Obes 1990; 14: 361-72
    • (1990) Int J Obes , vol.14 , pp. 361-372
    • McGuirk, J.1    Silverstone, T.2
  • 129
    • 0028024209 scopus 로고
    • m-Chlorophenylpiperazine decreases food intake in a test meal
    • Walsh AE, Smith KA, Oldman AD, et al. m-Chlorophenylpiperazine decreases food intake in a test meal. Psychopharmacology 1994; 116: 120-2
    • (1994) Psychopharmacology , vol.116 , pp. 120-122
    • Walsh, A.E.1    Smith, K.A.2    Oldman, A.D.3
  • 130
    • 0030609003 scopus 로고    scopus 로고
    • 5-HT2C activation decreases appetite and body weight in obese subjects
    • Sargent PA, Sharpley AL, Williams C, et al. 5-HT2C activation decreases appetite and body weight in obese subjects. Psychopharmacology 1997; 133: 309-12
    • (1997) Psychopharmacology , vol.133 , pp. 309-312
    • Sargent, P.A.1    Sharpley, A.L.2    Williams, C.3
  • 131
    • 0031016859 scopus 로고    scopus 로고
    • Sumatriptan decreases food intake and increases plasma growth hormone in women
    • Boeles S, Williams C, Campling GM, et al. Sumatriptan decreases food intake and increases plasma growth hormone in women. Psychopharmacology 1997; 129: 179-82
    • (1997) Psychopharmacology , vol.129 , pp. 179-182
    • Boeles, S.1    Williams, C.2    Campling, G.M.3
  • 132
    • 0026557374 scopus 로고
    • Clinical studies with d-fenfluramine
    • Guy-Grand B. Clinical studies with d-fenfluramine. Am J Clin Nutr 1992; 55 Suppl.: 173s-176s
    • (1992) Am J Clin Nutr , vol.55 , Issue.SUPPL.
    • Guy-Grand, B.1
  • 133
    • 0026776898 scopus 로고
    • Drug therapy after very-low-caloric diets
    • Finer N, Finer S, Nauova RP. Drug therapy after very-low-caloric diets. Am J Clin Nutr 1992; 56: 1955-85
    • (1992) Am J Clin Nutr , vol.56 , pp. 1955-1985
    • Finer, N.1    Finer, S.2    Nauova, R.P.3
  • 134
    • 0025666806 scopus 로고
    • Dieting reduces plasma tryptophan and alters brain 5-HT functioning in women
    • Anderson IM, Parry-Billings M, Newsholme EA, et al. Dieting reduces plasma tryptophan and alters brain 5-HT functioning in women. Psychol Med 1990; 20: 785-91
    • (1990) Psychol Med , vol.20 , pp. 785-791
    • Anderson, I.M.1    Parry-Billings, M.2    Newsholme, E.A.3
  • 135
    • 0025938842 scopus 로고    scopus 로고
    • Sibutramine in weight control: A dose-ranging, efficacy study
    • Weintraub M, Rubio A, Golik A, et al. Sibutramine in weight control: a dose-ranging, efficacy study. Clin Pharmacol Ther 1997; 50 (3): 330-7
    • (1997) Clin Pharmacol Ther , vol.50 , Issue.3 , pp. 330-337
    • Weintraub, M.1    Rubio, A.2    Golik, A.3
  • 136
    • 0030147221 scopus 로고    scopus 로고
    • A double-blind randomized placebo-controlled trial of sibutramine
    • Bray GA, Ryan DH, Grodon D, et al. A double-blind randomized placebo-controlled trial of sibutramine. Obes Res 1996; 4 (3): 263-70
    • (1996) Obes Res , vol.4 , Issue.3 , pp. 263-270
    • Bray, G.A.1    Ryan, D.H.2    Grodon, D.3
  • 137
    • 7144249179 scopus 로고    scopus 로고
    • Sibutramine predictability of long term weight loss
    • Smith I, Fitchet M, Kelly F. Sibutramine predictability of long term weight loss. Int J Obes 1997; 21 Suppl. 2; s53
    • (1997) Int J Obes , vol.21 , Issue.2 SUPPL.
    • Smith, I.1    Fitchet, M.2    Kelly, F.3
  • 138
    • 0028800705 scopus 로고
    • Serotonin and dietary fat intake: Effect of dexfenfluramine
    • Blundell JE, Lawton CL. Serotonin and dietary fat intake: effect of dexfenfluramine. Metabol Clin Exper 1995; 44 (2): 33-7
    • (1995) Metabol Clin Exper , vol.44 , Issue.2 , pp. 33-37
    • Blundell, J.E.1    Lawton, C.L.2
  • 139
    • 0023433843 scopus 로고
    • Changes in mood after carbohydrate consumption
    • Drewnowski A. Changes in mood after carbohydrate consumption [abstract]. Am J Clin Nutr 1987; 46: 703
    • (1987) Am J Clin Nutr , vol.46 , pp. 703
    • Drewnowski, A.1
  • 140
    • 0027460665 scopus 로고
    • Effects of dexfenfluramine treatment on body wight and postprandial thermogenesis in obese subjects: A double-blind, placebo-controlled study
    • Lafreniere F, Lambert J, Rasio E, et al. Effects of dexfenfluramine treatment on body wight and postprandial thermogenesis in obese subjects: a double-blind, placebo-controlled study. Int J Obes 1993; 17: 25-30
    • (1993) Int J Obes , vol.17 , pp. 25-30
    • Lafreniere, F.1    Lambert, J.2    Rasio, E.3
  • 141
    • 0001566450 scopus 로고    scopus 로고
    • The effect of dexfenfluramine on energy and macronutrient balance of obese women on high fat and low fat diets
    • Poppitt SD, Murgatroyd PR, Tainsh KR, et al. The effect of dexfenfluramine on energy and macronutrient balance of obese women on high fat and low fat diets [abstract]. Int J Obes 1997; 21 Suppl. 2: s65
    • (1997) Int J Obes , vol.21 , Issue.2 SUPPL.
    • Poppitt, S.D.1    Murgatroyd, P.R.2    Tainsh, K.R.3
  • 142
    • 1642415808 scopus 로고    scopus 로고
    • Risk factors for overeating: Dexfenfluramine suppresses the intake of sweet high fat or carbohydrate foods in obese women
    • Green S, Lawton C, Wales J, et al. Risk factors for overeating: dexfenfluramine suppresses the intake of sweet high fat or carbohydrate foods in obese women [abstract]. Int J Obes 1997; 21 Suppl. 2: s64
    • (1997) Int J Obes , vol.21 , Issue.2 SUPPL.
    • Green, S.1    Lawton, C.2    Wales, J.3
  • 143
    • 0030914304 scopus 로고    scopus 로고
    • The role of dietary fat in obesity
    • Golay A, Bobbioli E. The role of dietary fat in obesity. Int J Obes 1997; 21 (3 Suppl.): s2-11
    • (1997) Int J Obes , vol.21 , Issue.3 SUPPL.
    • Golay, A.1    Bobbioli, E.2
  • 144
    • 0026877323 scopus 로고
    • Food preferences in human obesity: Carbohydrates verses fats
    • Drewnowski A, Kurth C, Holden-Wiltse J, et al. Food preferences in human obesity: carbohydrates verses fats. Appetite 1992; 18: 207-1
    • (1992) Appetite , vol.18 , pp. 207-211
    • Drewnowski, A.1    Kurth, C.2    Holden-Wiltse, J.3
  • 145
    • 9444287592 scopus 로고    scopus 로고
    • Appetite suppressant drugs and the risk of primary pulmonary hypertension
    • Abenhaim L, Moride Y, Benot F, et al. Appetite suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996; 335: 609-16
    • (1996) N Engl J Med , vol.335 , pp. 609-616
    • Abenhaim, L.1    Moride, Y.2    Benot, F.3
  • 146
    • 0030876952 scopus 로고    scopus 로고
    • Valvular heart disease associated with fenfluramine-phentermine
    • Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997; 337: 581-8
    • (1997) N Engl J Med , vol.337 , pp. 581-588
    • Connolly, H.M.1    Crary, J.L.2    McGoon, M.D.3
  • 147
    • 0030807425 scopus 로고    scopus 로고
    • Death from irreversible pulmonary hypertension associated with short-term use of fenfluramine and phentermine
    • Dillon KA, Putnam KG, Avorn JL. Death from irreversible pulmonary hypertension associated with short-term use of fenfluramine and phentermine [letter]. JAMA 1997; 278: 1320
    • (1997) JAMA , vol.278 , pp. 1320
    • Dillon, K.A.1    Putnam, K.G.2    Avorn, J.L.3
  • 148
    • 0030853476 scopus 로고    scopus 로고
    • Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine
    • Mark EJ, Patalas ED, Chang HT, et al. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine. N Engl J Med 1997; 337: 602-6
    • (1997) N Engl J Med , vol.337 , pp. 602-606
    • Mark, E.J.1    Patalas, E.D.2    Chang, H.T.3
  • 149
    • 7144265249 scopus 로고    scopus 로고
    • Health advisory on fenfluramine/phentermine for obesity
    • Aug 27
    • Food and Drug Administration. Health advisory on fenfluramine/phentermine for obesity. Media Release 1997 Aug 27
    • (1997) Media Release
  • 150
    • 0030853477 scopus 로고    scopus 로고
    • Valvular heart disease associated with dexfenfluramine
    • Cannistra LV, Davis SM, Bouman AG. Valvular heart disease associated with dexfenfluramine [letter]. New Engl J Med 1997; 337: 636
    • (1997) New Engl J Med , vol.337 , pp. 636
    • Cannistra, L.V.1    Davis, S.M.2    Bouman, A.G.3
  • 151
    • 0031442220 scopus 로고    scopus 로고
    • High altitude may be synergistic with pulmonary hazards of appetite control medications fenfluramine and dexfenfluramine
    • Davis WM, Waters IW. High altitude may be synergistic with pulmonary hazards of appetite control medications fenfluramine and dexfenfluramine. Med Hypotheses 1997; 49: 509-12
    • (1997) Med Hypotheses , vol.49 , pp. 509-512
    • Davis, W.M.1    Waters, I.W.2
  • 152
    • 7144267316 scopus 로고    scopus 로고
    • Knoll Meridia blood pressure elevation screen should be created; BP concerns outweigh weight loss benefit for 39%-50% patients, FDA committee concludes
    • Sept 39
    • Knoll Meridia blood pressure elevation screen should be created; BP concerns outweigh weight loss benefit for 39%-50% patients, FDA committee concludes. F-D-C Pink Sheets 1996 Sept 39; 58: 10-1
    • (1996) F-D-C Pink Sheets , vol.58 , pp. 10-11
  • 153
    • 7144242697 scopus 로고    scopus 로고
    • Knoll's sibutramine rejected by US panel
    • Oct
    • Knoll's sibutramine rejected by US panel. Marketletter 1996 Oct 7: 18
    • (1996) Marketletter , vol.7 , pp. 18
  • 154
    • 10544251216 scopus 로고
    • Eating patterns in obesity
    • Stunkard AJ. Eating patterns in obesity. Psychiatr Q 1959; 33: 284-92
    • (1959) Psychiatr Q , vol.33 , pp. 284-292
    • Stunkard, A.J.1
  • 155
    • 0026534579 scopus 로고
    • Binge eating disorder: A multisite field study of the diagnostic criteria
    • Spitzer RL, Deslin M, Walsh BT, et al. Binge eating disorder: a multisite field study of the diagnostic criteria. Int J Eat Disord 1992; 11: 191-203
    • (1992) Int J Eat Disord , vol.11 , pp. 191-203
    • Spitzer, R.L.1    Deslin, M.2    Walsh, B.T.3
  • 156
    • 0027281085 scopus 로고
    • Is migraine related to the eating disorders
    • Brewerton TD, George MS. Is migraine related to the eating disorders. Int J Eat Disord 1993; 14: 75-9
    • (1993) Int J Eat Disord , vol.14 , pp. 75-79
    • Brewerton, T.D.1    George, M.S.2
  • 157
    • 0026595339 scopus 로고
    • Neuro-endocrine responses to m-chlorophenylypiperazine and l-tryptophan in bulimia
    • Brewerton TD, Mueller EA, Lesam MD, et al. Neuro-endocrine responses to m-chlorophenylypiperazine and l-tryptophan in bulimia. Arch Gen Psychiatry 1992; 49: 852-61
    • (1992) Arch Gen Psychiatry , vol.49 , pp. 852-861
    • Brewerton, T.D.1    Mueller, E.A.2    Lesam, M.D.3
  • 158
    • 0030271341 scopus 로고    scopus 로고
    • A direct measurement of satiety disturbance in patients with bulimia nervosa
    • Kissileff HR, Wentzlaff TH, Guss JL, et al. A direct measurement of satiety disturbance in patients with bulimia nervosa. Physiol Behav 1996; 60: 1077-85
    • (1996) Physiol Behav , vol.60 , pp. 1077-1085
    • Kissileff, H.R.1    Wentzlaff, T.H.2    Guss, J.L.3
  • 160
    • 0025614587 scopus 로고
    • The fluoxetine treatment of low weight, chronic bulimia nervosa
    • Solyom L, Solyom C, Ledwidge B. The fluoxetine treatment of low weight, chronic bulimia nervosa. J Clin Psychopharmacol 1990; 10: 421-5
    • (1990) J Clin Psychopharmacol , vol.10 , pp. 421-425
    • Solyom, L.1    Solyom, C.2    Ledwidge, B.3
  • 161
    • 0027372562 scopus 로고
    • Pharmacotherapy of bulimia nervosa - Experience with fluoxetine
    • Wood A. Pharmacotherapy of bulimia nervosa - experience with fluoxetine. Int Clin Psychopharmacol 1993; 8 (4): 245-9
    • (1993) Int Clin Psychopharmacol , vol.8 , Issue.4 , pp. 245-249
    • Wood, A.1
  • 162
    • 0029063763 scopus 로고
    • Long-term fluoxetine treatment of bulimia nervosa
    • Goldstein DJ, Wilson MG, Thompson VL, et al., Fluoxetine Bulimia Nervosa Research Group. Long-term fluoxetine treatment of bulimia nervosa. Br J Psychiatrv 1995; 166: 660-6
    • (1995) Br J Psychiatrv , vol.166 , pp. 660-666
    • Goldstein, D.J.1    Wilson, M.G.2    Thompson, V.L.3
  • 164
    • 0024314265 scopus 로고
    • A placebo-controlled study of trazodone in bulimia nervosa
    • Pope Jr HG, Keck Jr PE, McElroy SL, et al. A placebo-controlled study of trazodone in bulimia nervosa. Clin Psychopharmacol 1989; 9 (4): 254-9
    • (1989) Clin Psychopharmacol , vol.9 , Issue.4 , pp. 254-259
    • Pope Jr., H.G.1    Keck Jr., P.E.2    McElroy, S.L.3
  • 165
    • 0024314682 scopus 로고
    • Treatment of bulimia nervosa with trazodone: Short-term response and long-term follow-up
    • Hudson JL, Pope Jr HG, Keck Jr PE, et al. Treatment of bulimia nervosa with trazodone: short-term response and long-term follow-up. Clin Neuropharmacol 1989; 12 (1 Suppl.): s38-46
    • (1989) Clin Neuropharmacol , vol.12 , Issue.1 SUPPL.
    • Hudson, J.L.1    Pope Jr., H.G.2    Keck Jr., P.E.3
  • 167
    • 0029957925 scopus 로고    scopus 로고
    • D-fenfluramine treatment of binge eating disorder
    • Stunkard A, Berkowitz R, Tratikut C, et al. D-fenfluramine treatment of binge eating disorder. Am J Psychiatr 1996; 153: 1455-9
    • (1996) Am J Psychiatr , vol.153 , pp. 1455-1459
    • Stunkard, A.1    Berkowitz, R.2    Tratikut, C.3
  • 168
    • 0029825108 scopus 로고    scopus 로고
    • A double-blind, placebo-controlled trial of the effect of fluoxetine on dietary intake in overweight women with and without binge-eating disorder
    • Greno CA, Wing R. A double-blind, placebo-controlled trial of the effect of fluoxetine on dietary intake in overweight women with and without binge-eating disorder. Am J Clin Nutr 1996; 64: 267-73
    • (1996) Am J Clin Nutr , vol.64 , pp. 267-273
    • Greno, C.A.1    Wing, R.2
  • 169
    • 0027232955 scopus 로고
    • A placebo-controlled trial of d-fenfluramine in bulimia nervosa
    • Fahy TA, Elsler I, Russell GP. A placebo-controlled trial of d-fenfluramine in bulimia nervosa. Br J Psychiatry 1993; 162: 597-603
    • (1993) Br J Psychiatry , vol.162 , pp. 597-603
    • Fahy, T.A.1    Elsler, I.2    Russell, G.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.